A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

The heterogeneity of iCCA poses significant challenges to both targeted therapy and immunotherapy, necessitating in-depth exploration at the molecular and subtyping levels. Investigating genetic ...

Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...

Multidimensional tumor profiling and its meaningful impact on personalized therapy outcomes: Insights from a real-world study. Reporting an Indian multicentric community oncology practice’s ...

With more than three decades of experience supporting tens of thousands of clinical scans nationwide, Positron continues to position itself as a trusted partner to nuclear cardiology practices seeking ...

MedGenome to acquire a majority stake in Medcare Management Services, expanding its western India footprint and creating a ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...